June 9 (Reuters) - Immuron Ltd (IMC) :
- US DOD NAVAL MEDICAL RESEARCH CENTER REQUESTS MEETING WITH FDA FOR GUIDANCE ON TWO PHASE 2 TRIALS TO PREVENT ACUTE INFECTIOUS DIARRHEA
- IMMURON LTD - TWO HUMAN PHASE II CLINICAL TRIALS TO BE CONDUCTED IN 2021
- IMMURON - ONE TRIAL TO FOCUS ON ABILITY OF HYPERIMMUNE PRODUCT TO PROTECT VOLUNTEERS AGAINST MODERATE TO SEVERE CAMPYLOBACTERIOSIS
- IMMURON - SECOND TRIAL WILL FOCUS ON ETEC INFECTIONS
- IMMURON LTD - NMRC PLANS TO FILE IND APPLICATION LATER THIS YEAR, COMMENCE PHASE 2 CLINICAL STUDIES DURING H1 2021
- Forums
- ASX - By Stock
- News: IMC Immuron Says US DOD Naval Medical Research Center Requests Meeting With FDA On Two Phase...
June 9 (Reuters) - Immuron Ltd (IMC) : US DOD NAVAL MEDICAL...
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
9.3¢ |
Change
-0.005(5.10%) |
Mkt cap ! $21.20M |
Open | High | Low | Value | Volume |
9.6¢ | 9.6¢ | 9.2¢ | $21.53K | 230.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8315 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 21576 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 75838 | 0.091 |
1 | 500000 | 0.090 |
2 | 111235 | 0.089 |
2 | 61363 | 0.088 |
2 | 67804 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 21576 | 1 |
0.105 | 295769 | 3 |
0.110 | 121204 | 4 |
0.115 | 50000 | 1 |
0.120 | 138000 | 3 |
Last trade - 12.53pm 05/09/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |